tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market
CTNM
Contineum Therapeutics, Inc. Class A
RESEARCH TOOLSreports

Contineum Therapeutics, Inc. Class A (CTNM) Cash flow

212 Followers

Contineum Therapeutics, Inc. Class A Cash Flow

CTNM's free cash flow for Q4 2025 was $-13.08M. For the 2025 fiscal year, CTNM's free cash flow was decreased by $-22.18M and operating cash flow was $-13.04M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -55.31M$ -32.84M$ 19.35M$ -20.12M$ -26.27M
Investing Cash Flow
$ -3.71M$ -69.74M$ -65.57M$ 22.30M$ -64.97M
Financing Cash Flow
$ 112.69M$ 109.00M$ 56.18M$ -1.24M$ 79.84M
End Cash Position
$ 75.60M$ 21.94M$ 15.53M$ 5.57M$ 4.63M
Free Cash Flow
$ -55.54M$ -33.36M$ 18.93M$ -20.24M$ -26.43M
Currency in USD

Contineum Therapeutics, Inc. Class A Cash Flow